Accenture (ACN)
(Delayed Data from NYSE)
$308.00 USD
-0.52 (-0.17%)
Updated May 16, 2024 04:00 PM ET
After-Market: $307.20 -0.80 (-0.26%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACN 308.00 -0.52(-0.17%)
Will ACN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ACN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACN
Accenture (ACN) Stock Moves -0.17%: What You Should Know
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
ACN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Accenture (ACN) Stock Sinks As Market Gains: Here's Why
Accenture (ACN) Stock Sinks As Market Gains: What You Should Know
Brokers Suggest Investing in Accenture (ACN): Read This Before Placing a Bet
Other News for ACN
Accenture to Acquire OPENSTREAM HOLDINGS to Help Clients Advance Their Data-Driven Business Reinvention
Cognizant Technology gains on speculation of activist investor amid 13F filing
Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
Balancing Growth Prospects and Economic Challenges: Hold Rating on Accenture
Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development